BARCELONA—For children with intracranial ependymoma and measurable residue after first- or second-line surgery, a hypofractionated radiotherapy boost was feasible and improved local control—in a study presented to the 3rd ESTRO Forum. Lead author Lorenza Gandola MD, from Istituto Nazionale dei Tumori in Milan, explained to Oncology Times reporter Sarah Maxwell how they found that increasing the dose of radiotherapy significantly improved survival.
You may also like...
“Active Travel” to Save Many Lives, Billions of Dollars 10 Sep, 2012 ‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor 12 May, 2015 Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer 11 Feb, 2014 Prior Chemotherapy: No Bar to Checkpoint Inhibition in Mesothelioma 26 Apr, 2015
- Previous story Accelerated Partial Breast Irradiation for Women over 70 with Early Breast Cancer Improved Outcomes
- Next story Higher Radiation Dose Improved Survival in Children with Ependymoma
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014